Related Experiment Video
Updated: Feb 24, 2026

Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
Published on: May 12, 2023
[Neutrophil extracellular traps and coagulation dysfunction in sepsis]
Fangxiao Zhang1, Zhidan Zhang, Xiaochun Ma
1Department of Critical Care Medicine, the First Affiliated Hospital, China Medical University, Shenyang 110001, Liaoning, China. Corresponding author: Zhang Zhidan,
Neutrophil extracellular traps (NETs) restrict pathogens but can cause blood clotting issues in sepsis and venous thrombosis. These structures may serve as biomarkers for coagulation dysfunction and potential therapeutic targets.
Area of Science:
- Immunology
- Hematology
- Pathophysiology
Background:
- Neutrophil extracellular traps (NETs) are DNA and protein structures released by activated neutrophils.
- NETs function as a defense mechanism against pathogens.
- However, NETs are implicated in thrombosis and sepsis-related coagulopathy.
Purpose of the Study:
- To investigate the role of NETs in sepsis and venous thrombosis.
- To explore NETs as potential biomarkers for coagulation dysfunction.
- To evaluate NETs as therapeutic targets in sepsis.
Main Methods:
- Literature review on NETs' role in inflammation and coagulation.
- Analysis of studies linking NETs to sepsis-induced coagulopathy.
- Examination of research on NETs in venous thrombosis pathogenesis.
Main Results:
- NETs contribute to neutrophil-platelet adhesion and procoagulant activity.
- NETs can cause endothelial cell damage, exacerbating coagulopathy in sepsis.
- NETs are significantly involved in the pathophysiology of venous thrombosis.
Conclusions:
- NETs play a dual role in host defense and pathological thrombosis.
- NETs are potential biomarkers for assessing coagulation disorders in sepsis.
- Targeting NETs may offer a novel therapeutic strategy for sepsis and thrombosis.
More Related Videos
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Inflammation
Clot Retraction and Fibrinolysis

